Jacques Lespérance

Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty

Leonard Schwartz, Martial G. Bourassa, Jacques Lespérance et al. · New England Journal of Medicine · 1988 · 694 citations

Endovascular Technique, Pharmacotherapy, Coronary Artery Disease +16

The Relation of Risk Factors to the Development of Atherosclerosis in Saphenous-Vein Bypass Grafts and the Progression of Disease in the Native Circulation

Lucien Campeau, M Enjalbert, Jacques Lespérance et al. · New England Journal of Medicine · 1984 · 625 citations

Probucol and Multivitamins in the Prevention of Restenosis after Coronary Angioplasty

Jean‐Claude Tardif, Gilles Côté, Jacques Lespérance et al. · New England Journal of Medicine · 1997 · 567 citations

Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation.

Claude M. Grondin, Lucien Campeau, Jacques Lespérance et al. · PubMed · 1984 · 525 citations

Late Changes, Consecutive Series, Sv Grafts +14

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

David D. Waters, Lyall Higginson, Peter Gladstone et al. · Circulation · 1994 · 505 citations · Full text